{"id":89381,"date":"2023-01-06T06:10:00","date_gmt":"2023-01-06T06:10:00","guid":{"rendered":"https:\/\/quixnet.net\/2023\/01\/eisai-biogen-receives-u-s-fda-approval-for-alzheimers-drug-applies-for-full-approval-reuters\/"},"modified":"2023-01-06T06:10:00","modified_gmt":"2023-01-06T06:10:00","slug":"eisai-biogen-receives-u-s-fda-approval-for-alzheimers-drug-applies-for-full-approval-reuters","status":"publish","type":"post","link":"https:\/\/quixnet.net\/wpinstance\/eisai-biogen-receives-u-s-fda-approval-for-alzheimers-drug-applies-for-full-approval-reuters\/","title":{"rendered":"Eisai, Biogen receives U.S. FDA approval for Alzheimer’s drug, applies for full approval – Reuters"},"content":{"rendered":"
\n
    \n
  1. Eisai, Biogen receives U.S. FDA approval for Alzheimer’s drug, applies for full approval<\/a>Reuters<\/font><\/li>\n
  2. FDA Approves, Leqembi, New Treatment for Early Alzheimer’s<\/a>The New York Times<\/font><\/li>\n
  3. FDA greenlights new Alzheimer’s drug amid safety concerns<\/a>NBC News<\/font><\/li>\n
  4. Alzheimer’s drug lecanemab receives accelerated approval amid safety concerns<\/a>CNN<\/font><\/li>\n
  5. New Alzheimer’s drug offers hope to patients and caregivers | DW News<\/a>DW News<\/font><\/li>\n<\/ol>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

    Eisai, Biogen receives U.S. FDA approval for Alzheimer’s drug, applies for full approvalReuters FDA Approves, Leqembi, New Treatment for Early Alzheimer’sThe New York Times FDA greenlights new Alzheimer’s drug amid safety concernsNBC News Alzheimer’s drug lecanemab receives accelerated approval amid safety concernsCNN New Alzheimer’s drug offers hope to patients and caregivers | DW NewsDW News<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_genesis_hide_title":false,"_genesis_hide_breadcrumbs":false,"_genesis_hide_singular_image":false,"_genesis_hide_footer_widgets":false,"_genesis_custom_body_class":"","_genesis_custom_post_class":"","_genesis_layout":"","footnotes":""},"categories":[6],"tags":[],"class_list":{"0":"post-89381","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-business","7":"entry"},"_links":{"self":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts\/89381","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/comments?post=89381"}],"version-history":[{"count":0,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/posts\/89381\/revisions"}],"wp:attachment":[{"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/media?parent=89381"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/categories?post=89381"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/quixnet.net\/wpinstance\/wp-json\/wp\/v2\/tags?post=89381"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}